Aesthetics & Anti-Aging · Reviewed by Ian K. Tseng, MD

What Is GHK-Cu? The Copper Peptide, Topical and Otherwise

GHK-Cu is unusual among the compounds in this space because it has a substantial presence in two very different worlds: it is a well-established cosmetic skincare ingredient sold over the counter, and it is also prepared as a compounded injectable. The evidence supporting those two uses is not equally strong, and conflating them is the most common mistake in how this compound gets discussed.

Published August 4, 2026 · Medical review by Ian K. Tseng, MD, Medical Director

Soothe IV Med Spa branded amber pharmacy vial on warm marble, representing the aesthetics & anti-aging category of physician-supervised peptide therapy

The short answer

GHK-Cu is a naturally occurring tripeptide — glycyl-L-histidyl-L-lysine — bound to a copper ion. It is present in human plasma, saliva, and urine, and plasma concentration declines substantially with age. Research has examined roles in wound healing, collagen and elastin synthesis, and antioxidant activity. The strongest evidence relates to topical application; injectable preparations are compounded and less extensively studied.

A peptide your body already carries

GHK is a three-amino-acid sequence — glycine, histidine, lysine — with a strong natural affinity for copper. In the body it exists predominantly bound to copper as GHK-Cu, and it is found in plasma, saliva, and urine.

The frequently cited observation is the age-related decline: plasma GHK concentration is roughly 200 nanograms per milliliter around age twenty and falls to approximately 80 by age sixty. That decline correlates with the period during which skin regenerative capacity and wound-healing speed also decline, which is the origin of the interest in the compound.

Correlation is doing real work in that sentence, and it should be read as the reason the research was pursued rather than as the conclusion of it.

What the topical research supports

The best-developed evidence for GHK-Cu concerns topical application to skin. Studies have examined effects on collagen and elastin synthesis, glycosaminoglycan production, skin firmness and elasticity measures, and wound repair. This is why copper peptides appear as a named active ingredient across a wide range of serums and creams — the cosmetic use rests on a real literature.

Because topical GHK-Cu is a cosmetic ingredient rather than a drug, it does not require a prescription and its claims are cosmetic claims. Our article on topical versus injectable peptides explains why delivery route changes both the regulatory category and the physiological reality of what reaches which tissue.

Injectable preparations are a different question

Injectable GHK-Cu is a compounded preparation, prescribed individually and produced by a compounding pharmacy. It has not been through FDA pre-market review in that form, and the human clinical literature supporting systemic administration is considerably thinner than the topical dermatologic literature.

This is worth stating plainly because the marketing frequently borrows credibility across the boundary — citing topical skin studies in support of an injectable protocol. Those are different exposures, different tissue concentrations, and different evidence bases. A physician evaluating whether an injectable preparation is appropriate is making a judgment that the topical research does not settle.

Where it fits alongside aesthetic care

GHK-Cu sits in the aesthetics and anti-aging category of care, which is also where our device-based treatments live. Patients pursuing skin goals frequently combine approaches — systemic support alongside in-office treatments like RF microneedling and IPL, which act locally on the skin through entirely different mechanisms.

Whether any of this is appropriate for you, individually, follows the same path as everything else in the program: a Good Faith Exam, bloodwork, and a physician's determination. Not everyone qualifies, and skin goals in particular are often better served by a combination approach than by any single compound.

Frequently asked questions

What is GHK-Cu?

A naturally occurring tripeptide — glycyl-L-histidyl-L-lysine — bound to a copper ion. It is present in human plasma, saliva, and urine. Plasma concentration is roughly 200 nanograms per milliliter around age twenty and declines to approximately 80 by age sixty, a decline that parallels reductions in skin regenerative capacity.

Are copper peptides in skincare the same as injectable GHK-Cu?

They are the same molecule delivered by fundamentally different routes, with different evidence bases and different regulatory categories. Topical GHK-Cu is a cosmetic ingredient with a well-developed dermatologic literature on collagen and elastin synthesis and skin firmness. Injectable GHK-Cu is a compounded prescription preparation with considerably thinner human clinical literature. Topical research does not establish injectable outcomes.

What does the topical GHK-Cu research show?

Studies have examined effects on collagen and elastin synthesis, glycosaminoglycan production, measures of skin firmness and elasticity, and wound repair. This literature is the basis for copper peptides appearing as a named active ingredient in cosmetic serums and creams. As a cosmetic ingredient it does not require a prescription, and its claims are cosmetic rather than medical claims.

Can GHK-Cu be combined with in-office aesthetic treatments?

Patients pursuing skin goals frequently combine systemic and local approaches, and device-based treatments such as RF microneedling and IPL act on the skin through entirely different mechanisms. Whether any specific combination is appropriate is a clinical determination made after a Good Faith Exam and bloodwork.

Clinical references

Medically reviewed by Ian K. Tseng, MD, Medical Director of Soothe IV's peptide therapy program. The clinical statements in this article are supported by the following sources:

Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018. pmc.ncbi.nlm.nih.gov
Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015. pmc.ncbi.nlm.nih.gov
U.S. Food & Drug Administration. Human Drug Compounding. www.fda.gov

Ready to talk to a physician?

Start your $50 Application — the comprehensive intake, physician Good Faith Examination, and medical clearance. A physician reviews your goals and labs and tells you honestly whether therapy is appropriate. Your fee credits in full toward your first month of membership. Available nationwide.

Book & Pay for Your $50 Application

Serving Orange County, Los Angeles, and San Diego — plus nationwide telehealth. All service areas.

This article is educational and is not medical advice. Statements have not been evaluated by the FDA. Peptide therapy is a physician-supervised medical service; specific protocols are determined individually after a Good Faith Examination and bloodwork, and not all applicants qualify. Some compounded medications used in physician-prescribed protocols are not FDA-approved. Data from clinical trials on FDA-approved medications should not be used to make assessments related to compounded medications. Soothe IV's peptide program is available nationwide via telehealth; prescriptions are issued by physicians licensed in your state.